Phase Genomics logo — Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Ep...

Phase Genomics

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics

Founded 2015 United States Seattle, United States 13 employees Unknown Total: $22.59M Biotechnology, Clean Energy

General Information

Company Name Phase Genomics
Founded Year 2015
Location United States Seattle, United States +1
Founders / Decision Makers
Team member Team member
Employees 13
Industries Biotechnology, Clean Energy
Funding Stage Unknown
Social

Get notified when Phase Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Phase Genomics

Phase Genomics, founded in 2015, is a pioneering company in the Biotechnology and Clean Energy sectors, headquartered in the United States. The company is renowned for its tagline, "Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics", which encapsulates its commitment to advancing the field through innovative genomic analysis techniques.

Utilizing cutting-edge Hi-C and proximity-ligation technologies, Phase Genomics specializes in chromosome-scale genome assembly and metagenomic deconvolution. It offers a broad range of sophisticated laboratory and computational solutions, including Hi-C kits tailored for various biological samples and leading-edge genome assembly software. This enables its clients, both in academic and commercial domains, to undertake comprehensive structural genomic analyses.

The company's recent financing—a $1.50M grant from the Bill & Melinda Gates Foundation on 04 March 2024—attests to its strategic importance and potential for impact in the realms of scientific research and innovation.

Taxonomy: Genomics, Hi-C, Metagenomics, Bioinformatics, Genome Assembly, Microbiome, Scientific Research, Agriculture, Human Health, Industrial Biology, NGS (Next-Generation Sequencing), Diagnostic, DNA Sequencing, Cancer

Services & Products

Ultra-long-range Sequencing Technology
Proximity Genome Mapping
Computational Platforms for Genomic Analysis
Chromosome-scale Reference Genome Construction

Target Customers

Academic Research Organizations Biopharmaceutical Companies Biotechnology Institutes Scientists in Life Sciences and Medicine

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Mar 2024
Grant •••••• 2
Investor
•••• ••••
01 Aug 2023
Early VC •••••• - 01 Apr 2023
Grant •••••• 2
Investor Investor
01 Jun 2022
Grant •••••• 1
Investor
01 Feb 2021

View All 11 Funding Rounds

Phase Genomics Alternatives & Competitors

View All Alternatives
Phase Genomics vs
Genomics England
Genomics England United Kingdom

We’re working to enable faster and deeper genomic diagnosis & research, to bring genomic healthcare...

556 employees
Biotechnology, Health Care
Phase Genomics vs
Ultima Genomics
Ultima Genomics United States

Unleashing the power of genomics at scale

Seed
305 employees
Biotechnology, Health Care
Phase Genomics vs

Keeping pace with the evolving technology field to expand our role at the University and the wider b...

35 employees
Biotechnology, Education

FAQ About Phase Genomics

Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics
Phase Genomics was founded in 2015.
Phase Genomics is headquartered in Seattle, United States.
Phase Genomics operates in the following industries: Biotechnology, Clean Energy.
Phase Genomics has approximately 13 employees.
Phase Genomics has completed 11 funding rounds, raising a total of $22.59M. The latest funding stage is Unknown.
Phase Genomics offers: Ultra-long-range Sequencing Technology, Proximity Genome Mapping, Computational Platforms for Genomic Analysis, Chromosome-scale Reference Genome Construction.
Top alternatives and competitors to Phase Genomics include Genomics England, Ultima Genomics, University of Minnesota Genomics Center, MEDGENOME, Diagnomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phase Genomics and Genomics England are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Phase Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy